VIX Short-Term Futures ETN Ipath (VXX) 42.02 $VXX 3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
VIX Short-Term Futures ETN Ipath (VXX) 42.02 $VXX

3 Signs the Dow's Drop Is Just a Dip
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 07, 8:03PM CDT
The Dow Jones Industrials fell 166 points Monday, following up on Friday's similar losses and getting many investors fearful about the future of stocks. With the popular "sell in May" indicator just a few weeks away from triggering its seasonal...

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Pullback After Yesterday's Rally of 2.07%
Comtex SmarTrend(R) - Fri Apr 04, 3:43PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.25 to a high of $42.36. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $42.06 on volume of 48.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Don't Let These ETFs Fool You - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Tue Apr 01, 10:45AM CDT
Most ETFs are simple and transparent but investors need to be aware of a few potential pitfalls with some ETFs.

Look for Shares of iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound after Yesterday's 3.21% Sell Off
Comtex SmarTrend(R) - Mon Mar 31, 3:42PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.11 to a high of $43.15. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $43.30 on volume of 28.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 3.21%, iPATH S&P 500 VIX Short-Term Futures ETN Offers Investors Better Value
Comtex SmarTrend(R) - Mon Mar 31, 3:41PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.11 to a high of $43.15. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $43.30 on volume of 28.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Dow Correction: Why You Shouldn't Panic Over Market Volatility
Dan Caplinger, The Motley Fool - Motley Fool - Wed Mar 26, 3:30PM CDT
On Wednesday, the Dow Jones Industrials lost almost 100 points, finishing near the day's lows as investors worried about a variety of factors that could hurt the market's future prospects. That range of issues runs from the threat of war in...

'Fast Money' Recap: Opportunities in Technology
at The Street - Wed Mar 26, 4:00AM CDT
The trading panel discussed some familar names -- IBM, Hewlett-Packard and Qualcomm.

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound After Falling 3.94% Yesterday
Comtex SmarTrend(R) - Tue Mar 18, 3:44PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $43.31 to a high of $44.41. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $43.62 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Falls 3.94% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Mar 18, 3:44PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $43.31 to a high of $44.41. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $43.62 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

The Dow Gets Complacent Again, but is the Russia-Ukraine Conflict Really Over?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Mar 17, 11:30AM CDT
After the weekend's referendum on Crimea's rejoining Russia went much as expected, but without any huge escalation in the conflict, investors celebrated by sending the Dow Jones Industrials up nearly 190 points, or 1.2%, as of 12:30 p.m. EDT. At...

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Pullback After Gaining 4.04% Yesterday
Comtex SmarTrend(R) - Thu Mar 13, 3:41PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $43.62 to a high of $46.77. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of $45.57 on volume of 60.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

As the Dow Keeps Falling, Why Are Investors so Complacent?
Dan Caplinger, The Motley Fool - Motley Fool - Thu Mar 13, 11:30AM CDT
Throughout this week, the Dow Jones Industrials have performed in a much different way than they have throughout most of the past five years, with a 125-point drop as of 12:30 p.m. EDT pointing to the very real possibility of a fourth straight day...

After Yesterday's Rally of 2.16% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Mar 07, 3:41PM CST
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.60 to a high of $44.34. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $43.90 on volume of 34.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Five Most Liquid ETFs of 2014 - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Mar 06, 1:00PM CST
Looking for liquidity? Try these ETFs for returns.

Global Macro: Market Fears War, Global Assets Tumble
at The Street - Tue Mar 04, 5:00AM CST
Russia gives Ukraine an ultimatum and investors flee global equities for safety.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Macao's 25-Year Journey: Celebrating Growth and Prosperity

Updated Category News Views 161

Macao's Remarkable Development Over 25 Years In a vibrant celebration of progress, Macao recently marked the significant milestone of its 25th anniversary since its return to the motherland. A special publication by an English-language newspaper highlighted various achievements that the region has made during this transformative period. Economic Growth and Transformation...

Continue Reading
Opportunity to Address Losses: Join Tempus AI Class Action

Updated Category News Views 128

Investors Encouraged to Participate in Tempus AI Class Action The law firm Robbins Geller Rudman & Dowd LLP is actively reaching out to investors of Tempus AI, Inc. (NASDAQ: TEM) who have experienced notable financial losses. They have announced an opportunity for eligible investors to take the lead in an associated class action lawsuit. This potential action stems from...

Continue Reading
Muncy Columbia Financial Corporation's Strong Q4 2024 Earnings

Updated Category News Views 99

Muncy Columbia Financial Corporation's Financial Outlook Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), after releasing its unaudited consolidated financial statements for the fourth quarter of 2024, has demonstrated significant improvement over the previous year. Fourth Quarter 2024 Financial Highlights For the quarter ending December 31, 2024,...

Continue Reading
Caris Life Sciences Expands Cancer Research Alliance

Updated Category News Views 119

Caris Life Sciences Expands Cancer Research Alliance Caris Life Sciences® (NASDAQ: CAI), a forefront player in precision medicine and next-generation AI TechBio, is excited to share the arrival of Providence Swedish Cancer Institute into the esteemed Caris Precision Oncology Alliance (Caris POA). This addition enhances their collective mission to revolutionize cancer...

Continue Reading
Zumiez Inc. Gears Up for First Quarter 2025 Financial Report

Updated Category News Views 263

Upcoming Financial Report for Zumiez Inc. Zumiez Inc. (NASDAQ: ZUMZ) has recently made an exciting announcement regarding its financial performance. The company is set to release its first quarter results for fiscal 2025 on June 5, after the stock market closes. This pivotal moment is eagerly anticipated by investors and stakeholders alike, as it will provide valuable...

Continue Reading